potential indications for glp-1 receptor agonists keep expanding Safety and Tolerability of Glucagon-Like Peptide-1 Agonists: A State-of-the-Art Narrative Review | Drugs Beyond Blood Sugar: A Scoping
Description
1):623630 [DOI] [PubMed] [Google Scholar] 15.Lyseng-Williamson KA
Regulatory pathways benefit from extensive preclinical and clinical data supporting accelerated approval processes
CMSs efforts to provide Medicare coverage of GLP-1s for obesity could offer substantial benefits to millions of Medicare beneficiaries, given the high demand for these medications
From geroscience to precision geromedicine: Understanding and managing aging
10.1016/0024-3205(83)90237-0 11 DixonT
